Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

677 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.
Walker AM, Koro CE, Landon J. Walker AM, et al. Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):760-8. doi: 10.1002/pds.1598. Pharmacoepidemiol Drug Saf. 2008. PMID: 18383443
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.
Gruber S, Chakravarty A, Heckbert SR, Levenson M, Martin D, Nelson JC, Psaty BM, Pinheiro S, Reich CG, Toh S, Walker AM. Gruber S, et al. Among authors: walker am. Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):973-81. doi: 10.1002/pds.4065. Epub 2016 Jul 14. Pharmacoepidemiol Drug Saf. 2016. PMID: 27418432
Identifying health outcomes in healthcare databases.
Lanes S, Brown JS, Haynes K, Pollack MF, Walker AM. Lanes S, et al. Among authors: walker am. Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1009-16. doi: 10.1002/pds.3856. Epub 2015 Aug 18. Pharmacoepidemiol Drug Saf. 2015. PMID: 26282185 Review.
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R. Velentgas P, et al. Among authors: walker am. Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1350-8. doi: 10.1002/pds.3321. Epub 2012 Jul 16. Pharmacoepidemiol Drug Saf. 2012. PMID: 22807266
An event-based approach for comparing the performance of methods for prospective medical product monitoring.
Gagne JJ, Walker AM, Glynn RJ, Rassen JA, Schneeweiss S. Gagne JJ, et al. Among authors: walker am. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):631-9. doi: 10.1002/pds.2347. Epub 2012 Jan 4. Pharmacoepidemiol Drug Saf. 2012. PMID: 22223544 Free PMC article.
Orthogonal predictions: follow-up questions for suggestive data.
Walker AM. Walker AM. Pharmacoepidemiol Drug Saf. 2010 May;19(5):529-32. doi: 10.1002/pds.1929. Pharmacoepidemiol Drug Saf. 2010. PMID: 20309840
Signal detection for vaccine side effects that have not been specified in advance.
Walker AM. Walker AM. Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):311-7. doi: 10.1002/pds.1889. Pharmacoepidemiol Drug Saf. 2010. PMID: 20014170
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN, Kramer JM, Nakasato C, Spettell CM, Walker AM, Zhang F, Platt R. Velentgas P, et al. Among authors: walker am. Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1226-34. doi: 10.1002/pds.1675. Pharmacoepidemiol Drug Saf. 2008. PMID: 18956428
Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK, Castellsague J, Walker AM. Patterson MK, et al. Among authors: walker am. Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):982-8. doi: 10.1002/pds.1639. Pharmacoepidemiol Drug Saf. 2008. PMID: 18711705
Studies of diabetes, thiazolidinediones, and coronary heart disease.
Walker AM, McAfee AT, Koro C. Walker AM, et al. Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1313-4; author reply 1314-6. doi: 10.1002/pds.1498. Pharmacoepidemiol Drug Saf. 2007. PMID: 18041104 No abstract available.
677 results
Jump to page
Feedback